文献速递中药与中成药合理使用

清开灵注射液经激活过敏毒素C3诱导类过敏反应

Qing-Kai-Ling Injection Induces Immediate Hypersensitivity Reaction via the Activation of Anaphylatoxin C3.
PubMed 文献 · Front Pharmacol · 2020-01-09

本研究探讨清开灵注射液(QKLI)诱导速发型超敏反应的机制。采用LAD2人肥大细胞系、小鼠腹腔肥大细胞及Th2免疫增强小鼠模型,发现QKLI首次注射即可增加血管通透性并触发过敏反应,但不升高血清总IgE。机制上QKLI及板蓝根提取物直接激活补体C3,释放组胺介导类过敏反应,而非IgE介导的过敏。

要点

  • QKLI诱导的速发型超敏反应为补体激活相关类过敏反应,非IgE介导。
  • 板蓝根提取物是QKLI类过敏反应的主要贡献成分。
  • 组胺和C3a拮抗剂可阻断QKLI诱导的类过敏反应。

核心结论

  • QKLI诱导的速发型超敏反应是补体激活相关类过敏反应,而非IgE介导的过敏。
  • QKLI激活C3并可能由此促使肥大细胞释放组胺,组胺是其类过敏反应的主要效应物。
  • QKLI诱导的类过敏反应归因于板蓝根提取物。

研究设计与样本

  • 研究使用人肥大细胞系LAD2和小鼠腹腔肥大细胞进行β-氨基己糖苷酶释放实验。
  • 采用铝佐剂制备Th2免疫增强小鼠,通过直肠测温检测过敏性休克。
  • 使用Evans蓝外渗实验评估微血管通透性,ELISA检测血清总IgE和补体衍生过敏毒素C3a水平。

主要发现

  • QKLI不能升高Th2免疫增强小鼠的血清总IgE水平,但首次注射后可增加血管通透性并触发过敏反应。
  • 在QKLI的七个组分中,仅板蓝根(Isatis tinctoria L.)提取物诱导后爪Evans蓝外渗,而去除板蓝根的QKLI则无此作用。
  • QKLI或板蓝根引起的速发型超敏反应可被组胺或C3a拮抗剂阻断,而不被PAF或C5a拮抗剂阻断。
  • QKLI和板蓝根在体外可直接激活人血清补体衍生过敏毒素C3,半数有效浓度分别为0.69%和218.6 μg/ml。

临床怎么用

  • 临床应用QKLI时需警惕首次注射即可发生的类过敏反应,不应仅依赖IgE检测进行预测。
  • 对于QKLI类过敏反应的防治,可考虑针对C3激活或组胺效应的干预策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Objective: Qing-Kai-Ling (QKL) is derived from a famous ancient Chinese patent medicine Angong Niuhuang pills (ANP) which has been used across Asia, especially in China, for the treatment of "febrile disease," such as stroke, encephalitis and meningitis for hundreds of years. As an extract of ANP without heavy metal, the clinical applicability of QKL is more intensive, of which its injection is commonly used in acute and serious diseases. This study aims to clarify the potential mechanisms of immediate hypersensitivity reaction (IHR) induced by QKL injection (QKLI). Methods: β-hexosaminidase release assay was performed on the human mast cell line LAD2 and mouse peritoneal mast cells. T helper 2 (Th2) immunity-amplified mice were prepared by aluminum adjuvant. Anaphylactic shock was detected by measuring rectal thermometry in propranolol-pretreated mice. For evaluating microvascular permeability, Evans Blue extravasation assay was used. Serum total IgE (tIgE) and the activated complement-derived anaphylatoxin C3 (C3a) levels were measured by ELISA. Results: QKLI was unable to elevate serum tIgE level in the Th2 immunity-amplified mice, but can increase vasopermeability and trigger anaphylaxis after the first injection. By screening seven fractions of QKLI, only the extract of Isatidis Radix (Isatis tinctoria L.) induced hindpaw Evans Blue extravasation, which was disappeared in Isatidis Radix-free QKLI. Mechanism study indicated that QKLI or Isatidis Radix-caused IHR could be blocked by the antagonists for histamine or C3a, rather than PAF or C5a. Consistently, QKLI and Isatidis Radix could also directly activate human serum complement-derived anaphylatoxin 3 (C3) in vitro with the half effective concentration values of 0.69% and 218.6 μg/ml, respectively. Conclusion: QKLI-IHR is complement activation-related pseudoallergy, rather than an IgE-mediated allergy. QKLI activates C3 and might consequently provoke mast cells to release histamine, which is a principal effector of its IHR. The pseudoallergic reaction induced by QKLI was attributed to the extract of Isatidis Radix. This study suggests a potential therapeutic strategy for the prophylaxis and treatment of QKLI-IHR.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Gao Y, Qi R, Zhang X, et al. Qing-Kai-Ling Injection Induces Immediate Hypersensitivity Reaction via the Activation of Anaphylatoxin C3. Front Pharmacol. 2020. PMID: 31998128. doi:10.3389/fphar.2019.01524

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。